3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
HER2+ Metastatic Breast Cancer (MBC)
1
Interventions
zanubrutinib
1
venetoclax
1
pirtobrutinib
1
ibrutinib
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Waldenstrom Macroglobulinemia
×
Lapatinib
×
Clear all
No trials found.